Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Omegia is a health and nutrition company, operating as a primary brand of Puredia, that specializes in the development of standardized sea buckthorn-based ingredients. The company's flagship product, Omegia, is a clinically-validated formula containing a balanced ratio of Omega-3, 6, 7, and 9 fatty acids derived from organic sea buckthorn fruit and seed oil. Omegia focuses on therapeutic applications such as skin hydration, mucosal membrane health (addressing dry eye and vaginal dryness), and cardiovascular support. Their ingredients are sourced from the Tibetan Plateau and are utilized by global manufacturers in the dietary supplement, functional food, and personal care industries.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Omegia.